CorMedix (CRMD) Interest Coverage Ratio (2010 - 2026)
CorMedix (CRMD) posted Interest Coverage Ratio of 62.37 for Q4 2025, down 34114.17% sequentially from 0.18 in Q3 2025, and down 104.63% YoY from 1347.26 in Q4 2024.
CorMedix (CRMD) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
CorMedix has reported Interest Coverage Ratio for 15 years, with the latest figure at 62.37 in Q4 2025.
- Quarterly Interest Coverage Ratio fell 104.63% year-over-year to 62.37 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 170.47 (up 10.67% YoY) and the FY2025 annual result came in at 1.32, up 239.66% from the prior year.
- Interest Coverage Ratio declined to 62.37 in Q4 2025 per CRMD's latest filing, from 0.18 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1347.26 in Q4 2024 and troughed at 2389.99 in Q4 2023.
- A 5-year average of 296.35 and a median of 63.42 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio plunged 111912.64% in 2022, then soared 156.37% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 1446.62 in 2021, then soared by 96.8% to 46.28 in 2022, then sank by 5063.87% to 2389.99 in 2023, then soared by 156.37% to 1347.26 in 2024, then tumbled by 104.63% to 62.37 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 62.37, 0.18, and 8.19 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.85 |
| Dec 31, 2025 | -62.37 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 8.19 |
| Mar 31, 2025 | 37.97 |
| Dec 31, 2024 | 1,347.26 |
| Sep 30, 2024 | -64.46 |
| Jun 30, 2024 | -90.54 |
| Mar 31, 2024 | -98.84 |
| Dec 31, 2023 | -2,389.99 |
| Sep 30, 2023 | -209.35 |
| Jun 30, 2023 | -236.09 |
| Mar 31, 2023 | -220.34 |
| Dec 31, 2022 | -46.28 |
| Sep 30, 2022 | -139.24 |
| Jun 30, 2022 | -2,298.59 |
| Mar 31, 2022 | -6.15 |
| Dec 31, 2021 | -1,446.62 |
| Sep 30, 2021 | -9.00 |
| Jun 30, 2021 | -2.05 |